Vyleesi is the first and only as-needed treatment approved by the Food and Drug Administration (FDA) for premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD)
Biocon Biologics is one among the three pharmaceutical companies from India to be featured on this year's list
The findings of Phase 3 study are in line with Phase 2 study conducted in the US and Europe
Final stage in licensing OVM-200 from Oxford Vacmedix in the UK
European operations' revenue grew 58.4% to Rs 599.7 crore
We are redesigning Bayer to focus only on what’s essential for our mission, ‘Health for all, hunger for none’”
Tagrisso is projected to be a pivotal contributor to AstraZeneca’s portfolio
Oteseconazole Capsules were found to be safe and more effective than fluconazole
DKSH has further fortified its strategic partnership with Biolin Scientific, a globally recognized pioneer in surface science instrumentation, across nine key markets in the APAC region
Subscribe To Our Newsletter & Stay Updated
